Rodin Therapeutics retweeted
.@aj_rosenberg: It’s easy to lose hope when we see headline after headline announcing drug failures, but the @BIOConvention reminds us that innovation in Alzheimer’s research is thriving. #BIO2018 buff.ly/2kQsgWy
Rodin Therapeutics retweeted
Lots of promising hypotheses still being pursued. Keep the faith! teapawt.net/aj_rosenberg/status/10…
To kick off @BIOConvention in Boston this week, my Op/Ed in @BostonGlobe re: not giving up the fight to develop new treatments for @Alzheimers bostonglobe.com/opinion/2018…
Rodin Therapeutics retweeted
Many good points here...esp. re: #Alzheimers protein clearance or disaggregation approaches, where early and lengthy intervention is key. But, the catchy title is a bit of an overstatement - many of us are not giving up. qz.com/1282482/why-the-pharm…
Rodin Therapeutics retweeted
From yesterday's NYT, good piece on neuroplasticity, potential for selective hdac inhibition (our focus @rodintx) google.com/amp/mobile.nytime…
Rodin Therapeutics retweeted
Nice piece from @TheADDF on Advancing Epigenetics, with coverage of @Rodintx and our collaborator @HookerLab alzdiscovery.org/news-room/v…
Rodin Therapeutics retweeted
Replying to @aj_rosenberg
@Rock_Health pretty much seems to be the case across al industries catalyst.org/media/companies…
Rodin Therapeutics retweeted
And from my pre-Twitter life: Are We Poised for a Neuroscience Research Renaissance? Maybe lifescivc.com/2016/02/are-we…
Rodin Therapeutics retweeted
Welcome to the Twittersphere Adam Rosenberg, CEO of @Rodintx! Follow @aj_rosenberg for thoughts from the forefront of neuro drug discovery – at Cambridge, MA






